NABP dotPharmacy计划批准optimed.pharmacy为安全、可信的在线药店。

Kalamazoo, Mich. -​ OptiMed Health Partners announces receiving full domain approval from the .Pharmacy Verified Websites Program which enables American consumers to easily and quickly know which pharmacy sites are compliant with U.S. and state laws. Indicated on the .Pharmacy website, “Consumers can type in the name of the pharmacy's website with ".pharmacy" at the end: if the result leads to the pharmacy website, then it's legitimate.”

.Pharmacy程序包括在批准域名注册之前，由NABP进行审查，以确保申请人符合所有适用的计划标准，这些标准也涉及监管标准，包括药店执照和有效处方要求。申请人必须证明其信誉良好的执照，并遵守其所在辖区的法律，以及其开展业务的所有辖区的法律，包括但不限于在辖区内或向辖区内配发或运送处方药。

两家认证机构对OptiMed的质量、安全和卓越的患者护理的外部验证是.Pharmacy项目顺利通过验证的重要原因，因为它引导我们坚持医疗保健的最佳实践。

- Jessica Land，药房主任

OptiMed相信，通过获得经核实的、声誉良好的管理组织的认证，我们可以提供最高质量的医疗服务。作为全美首批100家获得卫生保健认证委员会（ACHC）和使用审查认证委员会（URAC）双重认证的专科药房之一，OptiMed保持着动态的质量保证和绩效改进计划，外部认证机构对我们的质量和安全进行认证。 OptiMed 在处方周转时间、电话服务、客户满意度、患者依从性和配药准确性等方面定期进行自我评估，不断超越业绩目标。

关于OptiMed：OptiMed Health Partners总部位于密歇根州卡拉马祖市，是一家独立经营的全国性医疗机构。凭借超过25年的经验，OptiMed注重个性化的细节，提供定制化的解决方案，优化患者的治疗效果，同时与其他医疗机构合作，开创了卓越的新标准。要了解更多有关OptiMed创新和个性化护理的信息，请访问optimed.pharmacy。

关于.Pharmacy。 .Pharmacy验证网站计划为各机构提供了一种简单而直接的方式，使其在可信和安全方面脱颖而出。NABP会对在线药店和与药物相关的网站进行审查，以确保它们获得适当的许可，并遵守适用的法律和商业最佳实践。更多信息，请访问nabp.pharmacy/programs/dotpharmacy。

OptiMed Health Partners推出新网站

OptiMed邀请访问者和热心的处方者浏览其新网站。

Kalamazoo, Michigan, December 21, 2019 (OptiMedHP.com) - OptiMed Health Partners, for its subsidiaries from specialty pharmacy to infusion services, designs a new website offering visitors the ultimate user-friendly experience with improved navigation, new features for patients and providers, and our aesthetics.

OptiMedHealthPartners.com and OptiMedSpecialtyRx.com are now OptiMedHP.com

以用户为中心创建的网站，包括许多新功能，帮助用户快速浏览网站并找到他们需要的适当信息。新功能包括：

• 导航栏中的推荐和注册表格按钮

• 快速响应功能--可兼容所有浏览器和设备。

• 全线服务--现在您可以在一个地方找到我们所有的服务和支持。

• 在线订购G.E.D.产品--可单独或批量提供。

We are very proud to announce the launch of our redesigned website. Visitors can find all of our services and products that OptiMed offers along with OptiMed’s vetted partners such as ASCEND and PotentiaMetrics..

订阅我们的季刊，了解最新的OptiMed和行业新闻。它包含了丰富的内容，包括有价值和有形的提示、新闻发布、特色产品和即将到来的药物批准。

For more information on OptiMed Health Partners, explore their new site; email them at info@optimedhp.com, or give them a call at 877.232.2857.

药剂师宣布HERO评分结果，挑战医疗保健行业，以实现可衡量的患者疗效改善和卓越价值。

OptiMed's breakthrough algorithm radically changes how employers evaluate the quality and value of their specialty pharmaceutical spending.

KALAMAZOO, Mich., November 5, 2019 (Newswire.com) - OptiMed Specialty Pharmacy announced the release of a case study demonstrating the Health Economics Return & Outcomes (HERO) Score for an inflammatory bowel disease (IBD) patient on a high-cost specialty medication.  Their breakthrough algorithm changes how employers critically evaluate the quality and value of their specialty pharmaceutical spending. 

"The calculation of the HERO Score provides valuable insight about a patient's health outcomes and the value their specialty medication provides," says Chad Henry, PharmD, CSP, a senior clinical pharmacist from OptiMed Specialty Pharmacy who led the research with a fellow colleague, Lucas Dominick, PharmD. "This could change how employers benchmark and deliver measurable improvements in patient outcomes and healthcare spending."

Chad Henry，药学博士，CSP，高级临床执行员

OptiMed assists employers in evaluating the return on healthcare dollars invested from specialty pharmaceuticals, which are a major force driving pharmacy benefit costs.

Despite being utilized by only 2% of the population, these high-cost medications account for approximately 45% of the total drug spend. 1. When including drug spending under the medical benefit, this number increases to 60% of the total drug spend. 2. The correlation between the high cost of specialty drugs and the value these medications provide to employees and employers has been difficult to estimate. The HERO Score provides an understanding of outcomes that can be viewed in aggregate to empower health plans and employers to choose their healthcare investments wisely and with confidence. 

In this highlighted case study, the HERO Score demonstrates how costs and outcome variables, such as drug price, site of infusion care, patient management, patient disease control, healthcare utilization, and quality of life, impact the value obtained from the use of a specialty medication in an inflammatory bowel disease (IBD) patient. Results indicated marked improvement in the patient outcomes and quality of life over the course of a year once transitioned to OptiMed Specialty Pharmacy.  The value obtained from the patient’s medication therapy was far superior due to better disease control, improved quality of life, reduced healthcare utilization, and enhanced productivity. This emphasizes the importance of a value assessment that incorporates all the cost variables and outcomes of any given regimen. To read the case study, click here to download the findings.

About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, email connect@optimedhealthpartners.com.

About Harmonize. Healthcare:  To learn more about the Health Economics Return & Outcomes (HERO) Score, click here to download the paper or visit HARMONIZE.HEALTHCARE (H2) to learn about applying novel care strategies to positively impact your organization and truly revolutionize employee health and productivity.

资料来源(1)Express Scripts 2018年药品趋势报告。2019年2月发布。载于：https://my.express scripts.com/rs/809VGG836/images/Express%20Scripts%202018%20Drug%20Trend%20Report.pdf。 2019年8月8日访问。(2) Shah, P. Today's Specialty Landscape.CVS Health Insights/Specialty.Available at: https://payorsolutions.cvshealth.com/insights/todays-specialty-landscape. 2019年10月8日访问。

CEO在播客上发表对专科药房配送降低成本的见解

在"重建医疗"播客中，OptiMed帮助雇主发现新的专科药房分销渠道以降低成本。

KALAMAZOO, Mich., October 14, 2019 (Newswire.com) - The cost of healthcare continues to rise, with the cost of employee health benefits expected to near $15,000 on average in 2019.1  As the single largest providers and purchasers of health insurance in the US, employers cover over 150 million workers and dependents, purchasing 34% of all healthcare.2  Of growing concern are numerous new and pricey prescription drugs, known as specialty pharmaceutical products, often noted as a key culprit behind rising healthcare costs.

In the Reconstructing Healthcare episode #54, podcast host, Michael Menery, introduces Andy Reeves, the Co-owner and CEO of OptiMed Health Partners. Join us as we discuss how OptiMed Specialty Pharmacy brings transparency to the market and helps employers understand and realign traditional specialty pharmacy distribution channels to lower costs.

Discussion topics include specialty drugs, specialty pharmacy vs. retail pharmacy, pharmacy benefits, misaligned incentives, price transparency, medication adherence vs. compliance, quality of care, and cost savings. Given their substantial financial investment into employee health, employers are justified in asking whether healthcare expenditures contribute to improved employee health, productivity, and the bottom line. Listen to the podcast and learn why OptiMed is a chosen partner for superior cost savings and better-quality care for patients.

About OptiMed:  OptiMed Health Partners is an independently owned and operated national healthcare organization, specialty pharmacy, and infusion services. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence.

About Reconstructing Healthcare:  Reconstructing Healthcare is a podcast series that explores what is wrong with the current healthcare system in the US, examines what drives higher healthcare costs, and exposes deficiencies in traditional insurance products. Join us as we interview companies and entrepreneurs that are providing innovative services and solutions designed to not only disrupt the health insurance marketplace but deliver lower costs and better value for your employees.

资料来源 (1)Miller, S. For 2019, Employers Adjust Health Benefits as Costs Near $15,000 per Employee.August 13, 2018. SHRM（在线）。Available at: https://www.shrm.org/resourcesandtools/hr-topics/benefits/pages/employers-adjust-health-benefits-for-2019.aspx.2019年2月13日访问。(2)美世调查。2018年9月18日。https://www.mercer.com/newsroom/mercer-survey-shows-employers-face-increase-in-health-benefit-cost-in-2018.html。 2019年10月8日访问。

ASCENDpbm推出算法，将工作效率与医疗成果和价值联系起来。

公布一个突破性的价值方程，让雇主对专业医疗投资有深入的了解。

在这里或下面阅读文章。

美国 密歇根州卡拉马祖市，2019年9月11日（新闻联播）--不理想的健康状况每年给美国雇主带来数十亿美元的损失。与健康状况不佳有关的缺勤，每年给美国雇主造成的成本高达2258亿美元，令人震惊。随着员工健康福利成本的不断上升，预计2019年的平均成本将接近1.5万美元。

单纯的成本并不能转化为医疗保健的价值。 大多数企业都会仔细跟踪与健康相关的直接成本。然而，许多企业没有方法分析可能影响这些支出的相应价值的众多因素，无论是积极的还是消极的。考虑到他们在员工健康上的大量财务投资，雇主有理由询问医疗保健支出是否有助于提高员工的健康和生产力，以及底线。

HERO Score为雇主提供了必要的洞察力，以实现对其独特劳动力最重要的健康结果。通过将多种健康结果变量提炼成一个 简单易懂的价值分值，雇主可以看到他们的医疗保健投资如何影响员工的生产力，并为他们的组织提供价值。

ASCENDpbm已与OptiMed Health Partners合作，利用健康经济回报与结果（HERO）得分，协助雇主评估医疗投资的回报。这个衡量的分数严格评估了专科药品提供的价值，而专科药品是推动药房福利成本的主要力量。

"与旷工不同，旷工并不总是显而易见的。你知道一个人什么时候没来上班，但你往往无法判断疾病或健康状况何时或在多大程度上影响了一个人的工作"。

在此下载论文。 了解更多关于Harmonize.Healthcare应用新颖的护理策略对您的组织产生积极影响的信息，在利益相关者之间保持清晰和及时的沟通，执行有针对性的干预措施，并利用先进的分析技术实时监控绩效；Harmonize.Healthcare网络有可能真正彻底改变员工的健康和生产力。

关于ASCENDpbm。ASCENDpbm是一家处方福利管理组织，通过使用透明度、技术、适当的使用和改善患者的结果来降低医疗成本，从而打破现状。要了解更多关于ASCENDpbm的信息，请访问www.ascendpbm.com。

关于Harmonize.Healthcare。 Harmonize.Healthcare的存在是为了提供一个透明的、以患者为中心的网络，由一流的医疗创新者合作，以颠覆传统的医疗服务模式。该计划对于帮助雇主了解其医疗决策的结果，并优化为其员工提供有效的基于价值的医疗服务至关重要。要了解更多关于Harmonize.Healthcare及其倡议的信息，请访问HARMONIZE.HEALTHCARE。

来源：ASCENDpbmASCENDpbm

OptiMed公布了今年西密歇根州最佳和最有前途的公司。

在员工成就、认可、沟通和共同愿景方面的最高评价。

KALAMAZOO, Mich., June 14, 2019 (Newswire.com) - ​​OptiMed Health Partners was recently named one of “West Michigan’s Best & Brightest Companies to Work For®.” This awards competition recognizes those companies that deliver exceptional human resource practices, innovative solutions, and an impressive commitment to their employees, creating richer lives and building a stronger workplace.​

Consecutively for three years in a row, OptiMed Health Partners has been awarded this prestigious national honor with top remarks in employee achievement, recognition, communication, and shared vision. Additional categories include enrichment, engagement, retention, diversity and inclusion, and strategic company performance. OptiMed is an independent health provider of pharmacy, specialty pharmacy, and infusion services – serving patients nationwide in all 50 states. For more than 25 years, OptiMed has supported people with complex and chronic conditions by ensuring patients receive the proper treatment at the right time.

OptiMed has been working hard to make a difference in our employees' lives and enhance their work experience. With company-wide pride, a commitment to patient care, and a knack for solving overlooked healthcare challenges, we're setting a new standard for the people we partner with and the patients we care for.

安迪-里夫斯，RPh，CEO

An independent research firm evaluates each company’s entry based on key measures in various categories. They include Compensation, Benefits, and Employee Solutions; Employee Enrichment, Engagement, and Retention; Employee Education and Development; Recruitment, Selection, and Orientation; Employee Achievement and Recognition; Communication and Shared Vision; Diversity and Inclusion; Work-Life Balance; Community Initiatives; Strategic Company Performance and the Best of the Best Small Business, Medium Business, and Large Business. 

Driven to improve health care, OptiMed enhances the patient experience by optimizing health outcomes and quality of life through personalized, coordinated care and excellent service. Their care team is trained in the complexity of specialty medications, patient safety, and quality. Some medications require complex documentation for costs to be covered. OptiMed's care team investigates prescription and healthcare insurance benefits, so there are no surprises regarding treatment costs.

“We are honored to recognize the efforts of this year’s 'Best and Brightest' companies. These companies have created impressive organizational value and business results through their policies and best practices in human resource management. This award has become a designation sought after by hundreds of West Michigan companies and is a powerful recruitment tool in the drive to attract and retain exceptional employees,” said Jennifer Kluge, President, and CEO, Best and Brightest Programs.

These medications treat complex chronic diseases and require specialized handling and administration as part of their distribution process. OptiMed is dual-accredited by the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC) to handle high-cost or high-risk medications that treat complex medical conditions, such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, immunodeficiency, hepatitis C and more. OptiMed is a resource – not just a supplier of medication – and offers a variety of benefits to patients, including free delivery of all medication and supplies, proactive refills, and financial support services.

获奖企业还将角逐13个精英奖，每个类别授予一个奖项。此外，在所有类别中表现突出的总冠军将被授予"最佳综合奖"。精英奖得主将在午餐会上揭晓。

Winners are pooled by the size of their company. Employers with 100 or fewer employees are benchmarked together and are classified as Small Business; 101-300 employees are benchmarked together and are classified as Medium Business; employers with more than 301 employees are benchmarked together and are classified as Large Business. No matter their size, all companies can be a Best and Brightest Companies to Work For®, resulting in Better Business, Richer Lives, and Stronger Communities.

The annual symposium and awards program began with registration, networking, and exhibit gallery preview at 8:00 a.m., followed by education. The breakfast and awards presentation was emceed by Juliet Dragos of WZZM 13 News and Steve Kelly of NewsRadio WOOD 1300. West Michigan’s Best and Brightest Companies to Work For® is sponsored by BASIC, Baudville Brands, Blue Cross Blue Shield of Michigan, ABC 13 News, Newsradio WOOD 1300 and 106.9 FM, Grand Rapids Business Journal, Davenport University, DTE Energy, Kelly Services, Marsh & McLennan Agency LLC, The Employers' Association, National Diagnostic Services, Consumers Credit Union, Paylocity, Schupan & Sons, and SpartanNash.

About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, email connect@optimedhealthpartners.com.

About Best and Brightest Companies to Work For®​:  This program allows the business community to gain recognition, showcase their best practices, and demonstrate why they are an ideal place for employees to work. This national program celebrates those companies making better business, creating richer lives, and building a stronger community. It is presented annually in several markets, including Atlanta, Boston, Chicago, Dallas, Detroit, Houston, Milwaukee, San Diego, San Francisco Bay Area, West Michigan, and nationally. Nominations are now being accepted. Visit www.thebestandbrightest.com to obtain an application.

OptiMed专科药房获得URAC专科药房再认证的全面认证。

凸显OptiMed的安全药学实践和优质的患者护理服务

KALAMAZOO, Mich., November 28, 2018 (Newswire.com) - OptiMed Health Partners announced that it was awarded an additional three-year specialty pharmacy accreditation from URAC, a Washington, D.C., health care accrediting organization that assesses quality standards for the health care industry. URAC’s specialty pharmacy accreditation symbolizes excellence for organizations to showcase their commitment to quality and accountability.

“OptiMed is pleased to receive this accreditation from URAC, as it highlights our commitment to delivering excellence and value from the specialty pharmacy services we provide to our diverse client base,” said OptiMed Founder and CEO Andrew Reeves R.Ph. “As the industry brings more life-changing and often costly therapies to the specialty market, it is our responsibility and honor to provide stakeholders a meaningful measure to determine the value of these medications.”

Delivering more than just medications, OptiMed provides patients with comprehensive care, clinical management, insurance investigators, resources, and tailored support services. OptiMed’s clinical pharmacists, with advanced training, coach patients through their treatment journey. Licensed, certified pharmacy technicians promote adherence, safety, and quality while essential patient support personnel create a positive, lasting impact on patient’s lives. OptiMed is best-in-class for chronic and rare specialty diseases such as Crohn’s, hepatitis C, HIV/AIDS, psoriasis, and rheumatoid arthritis. OptiMed Specialty Pharmacy also holds specialty pharmacy accreditation from the Accreditation Commission for Health Care (ACHC) and is licensed to provide services to patients nationwide.

“It’s necessary for specialty pharmacies to provide a higher level of patient treatment to achieve desired outcomes. OptiMed Specialty Pharmacy shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Kylanne Green. “With URAC accreditation, people know that OptiMed Specialty Pharmacy strives to adhere to industry best practices."

URAC promotes a high standard of pharmacy quality and patient care through the standardization of processes and a drive for continuous quality improvement. Accreditation reinforces best clinical and organizational practices for ensuring appropriate and safe medication use and optimal patient outcomes. Evidence of therapy counseling, disease education, care coordination, comprehensive patient education, and adherence management is critical for assuring successful patient medication therapy management and safety – and all are standards validated by URAC’s specialty pharmacy accreditation.

“We are extremely pleased to have achieved this designation,” said OptiMed's Director of Pharmacy, Jessica Ninke, PharmD. “Accreditation is a rigorous process that we welcome as a continuous quality improvement mechanism. Earning URAC full specialty pharmacy re-accreditation is another measure of our continued excellence as a premier provider of specialized pharmacy services. It reflects our commitment to our patients, as well as our health care providers and partners.”

About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, email connect@optimedhealthpartners.com.

About URAC:  Founded in 1990, URAC is the independent leader in advancing healthcare quality through leadership, accreditation, measurement, and innovation. URAC offers a wide range of quality benchmarking programs that reflect the latest changes in health care and provide a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. URAC’s evidence-based measures and standards are developed through inclusive engagement with various stakeholders committed to improving healthcare quality. For more information, visit www.URAC.org.

来源：OptiMed Health PartnersOptiMed Health Partners

OptiMed Health Partners和PotentiaMetrics推出颠覆性癌症结果平台

MyCancerJourney为患者提供可操作的信息，以改善患者在癌症治疗中的体验和结果。

KALAMAZOO, Mich., October 17, 2018 (Newswire.com) - OptiMed Health Partners, a Kalamazoo, Michigan based Specialty Pharmacy and Infusion healthcare provider, announced it has partnered with PotentiaMetrics data and artificial intelligence company to launch MyCancerJourney, a shared decision-making platform for cancer treatments.

MyCancerJourney was developed with researchers at Washington University School of Medicine in St. Louis to provide patient-specific survival estimates and improve the health outcomes of patients with cancer.

OptiMed Health Partners will be able to enhance the value of their oncology care program for their patients and clients by offering this personalized medical information platform for their patients. Patients can make better treatment decisions with their healthcare providers and improve their treatment experience during their cancer treatment journey.

“We are thrilled to work alongside OptiMed. Both of our companies are focused on personalized approaches to healthcare that lead to improved outcomes and better value. Together, we will provide personalized information to patients and address the high cost of cancer treatment in a meaningful way,” says Robert Palmer, CEO of PotentiaMetrics.

“We are excited to include this innovative platform (MyCancerJourney) to our arsenal of tools to improve patient outcomes in cancer and add real value to the healthcare ecosystem. I have seen many analytical and AI healthcare solutions, but MyCancerJourney is one of the very few solutions that live up to the hype and gets me excited about the future of healthcare,” says OptiMed CEO Andy Reeves. 

About PotentiaMetrics: PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs. To learn more about PotentiaMetrics, visit www.potentiametrics.com, or to learn more about MyCancerJourney, visit www.mycancerjourney.com.

About OptiMed Health Partners: OptiMed Health Partners, based in Kalamazoo, Michigan, is dually accredited by the Accreditation Commission for Health Care (ACHC) and URAC, specializes in treatments for rare and chronic conditions, such as rheumatoid arthritis, Hemophilia, multiple sclerosis, oncology, psoriasis and more. The organization has decades of experience offering personalized solutions that bring meaningful value to stakeholders.

OptiMed专科药房与PMD医疗合作，提供患者护理协调中心。

OptiMed专科药房将与PMD医疗保健公司合作，提供战略中心服务，加快并简化患者和医疗服务提供者对PMD医疗保健公司的个人肺活量计、Spiro PD 2.0和健康管理服务的访问。

密歇根州卡拉马祖，2017年9月19日（新闻联播）--OptiMed专科药房将与PMD医疗保健公司合作，提供战略枢纽服务，加快并简化患者和供应商对PMD医疗保健公司个人肺活量计、Spiro PD 2.0和健康管理服务的访问。 

A spirometer is a medical device used to measure lung function for a variety of diseases, including, but not limited to, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and lung transplant. Historically, this type of testing could only be conducted using larger equipment in a medical office. Spiro PD 2.0, however, allows patients to perform this important testing anytime and anywhere using a small, easy-to-use hand-held device. The device also provides patient reminders and alerts to help improve medication adherence.

​OptiMed Specialty Pharmacy will serve as the conduit between PMD Healthcare and the patient and payer by performing essential patient services such as insurance benefit verification, prior authorization support, patient assistance program administration, and care coordination, ensuring that product fulfillment and delivery is simple, efficient, and effective for patients.  

"在OptiMed，我们认为这种战略合作关系与我们的使命自然而然地契合，即关注影响患者体验的小细节，并利用这种对细节的个性化关注，提供优化患者疗效的定制化解决方案，"OptiMed专科药房首席执行官Andy Reeves博士说。

​OptiMed Specialty Pharmacy is devoted to optimizing health outcomes and quality of life through personalized and coordinated care and excellent service. OptiMed has 20+ years of experience collaborating with providers, payers, healthcare systems, and manufacturers and is one of the first 100 specialty pharmacies in the nation to be dually accredited by the Accreditation Commission for Health Care (ACHC) and URAC. For more information, call 877-232-2857.

杂志将OptiMed Specialty Pharmacy评为全美增长最快的私营公司之一。杂志将OptiMed Specialty Pharmacy评为美国增长最快的私营公司之一。

OptiMed在5,000家独立的中小型企业中排名第729位，被认为是全美最成功的公司之一。OptiMed在密歇根州排名第12位，在顶级医疗保健公司中排名第56位。

密歇根州卡拉马祖，2017年8月30日（ 美国新闻网）--《公司》杂志将OptiMed Specialty Pharmacy评为2017年美国发展最快的私营企业之一。

在被认为是全美最成功的公司的5000家独立中小型企业中，OptiMed排名第729位。微软、戴尔、Zillow和其他知名企业过去也曾获得过这一殊荣。OptiMed在密歇根州排名第12位，在顶级医疗保健公司中排名第56位。

"我们很荣幸获得这一殊荣，"OptiMed的首席执行官Andy Reeves，RPh说。"我们的发展直接反映了我们有能力满足医疗保健市场对以患者为中心的护理模式的需求，提供可衡量的价值。我们期待着继续成为全国范围内创新和协作式医疗服务的先锋。"

Inc.5000的总收入估计为2060亿美元，这些公司在过去三年中共创造了619,500个就业机会。榜单上的公司平均实现了惊人的三年平均增长481%。

OptiMed专科药房致力于通过个性化的协调护理和优质的服务来优化健康成果和生活质量。OptiMed在提供专科药房服务和医疗保健合作方面拥有20多年的经验，获得了医疗保健认证委员会（ACHC）和URAC的双重认证。

美国西密歇根州产生了29家发展最快的私营公司。

当地一家金融服务公司是全美增长最快的第10家私营公司，也是密歇根州入选2017年"公司5000强"排名的公司中的第一家。

Inc.杂志每年都会根据前三年的收入增长情况，对美国增长最快的私营企业进行排名。

总部位于Grand Rapids的FormulaFolio投资公司今年以13926.81%的增长率和1720万美元的营收赢得了排名的第10位。这是该公司连续第三年进入公司排名，从2015年的第944位攀升至2016年的第15位。

今年西密歇根州其他排名较高的公司还包括排名第49位的Boost营销集团、排名第168位的第五轮货运公司和排名第214位的Mobile Defenders。

今年，密歇根州有101家公司入选"公司5000强"，比去年的118家和2015年的110家有所减少。

按行业分列的增长情况

根据Inc.的数据，今年的排名显示，全美增长最快的行业是旅游和酒店业，增长率为201%，其次是媒体业，增长率为198%，能源业增长率为174%。

按国家分列的增长情况

根据排名，增长最快的州是加州，其次是德克萨斯州和佛罗里达州，增长最快的都市是纽约，其次是华盛顿特区和洛杉矶。

西密歇根州企业入选2017年"公司5000强"

10.FormulaFolio投资公司，大急流城，增长13926.81%，收入1720万美元，金融服务。

49.Ada的Boost营销集团，增长6269.28%，收入1100万，广告和营销。

168.第五轮货运公司，大急流城，增长2 463%，收入980万美元，物流和运输

214.移动卫士，肯特伍德，增长2 019%，3580万美元，电信。

572.大河无菌制造公司，大急流，增长791%，营收1910万美元，健康。

729.卡拉马祖的OptiMed专业药房，增长628%，收入7070万美元，健康。

1,060.Finix，大急流城，增长399%，收入700万美元，健康。

1,071.IP咨询公司，肯特伍德，增长395%，收入1110万美元，IT服务。

1,309.运动Addix，Lowell，增长312%，收入330万美元，消费产品和服务。

1,346.Workbox Staffing，大急流城，增长303%，收入4840万美元，人力资源。

1,552.创意工作室促销，大急流城，增长258%，收入240万美元，广告和营销。

1,654.Spice Jungle，Rockford，增长237%，收入470万，食品和饮料。

2,745.Pro-Vision，拜伦中心，增长125%，收入1320万美元，制造。

2,758.Blackford Capital，大急流城，增长124%，收入610万美元，金融服务。

3,017.平河集团，贝尔丁，增长110%，收入5070万，物流运输。

3,070.Reliable Relamping，Saranac，108%的增长，1880万美元的营收，能源。

3,120.荷兰Worksighted公司，增长105%，收入1020万美元，IT服务。

3,301.盛大变形金刚，盛大文创，增长96%，收入2910万，制造。

3,436.Sun Title Agency，大急流城，91%的增长，790万美元，房地产。

3,459.服务教授，大急流城，增长90%，收入610万美元，消费产品和服务。

3,780.卡拉马祖的AmeriFirst住房抵押贷款，增长78%，收入8280万美元，金融服务。

4,083.孔雀地产，莫利，增长68%，营收2030万，房地产。

4,284.荷兰EBW电子公司，增长61%，营收4380万美元，制造。

4,497.哈德逊维尔的格兰设备公司，增长55%，收入3560万美元，建筑业。

4,532.服务快车，大急流城，增长54%，收入7040万美元，IT服务。

4,585.美国金融，艾达，增长53%，收入3790万美元，金融服务。

4,702.圣约瑟夫的Edgewater Automation，增长49%，收入3530万美元，制造。

4,711.Custom Profile，大急流城，49%的增长，4060万美元的收入，制造业

4,858.优质铝制品公司，黑斯廷斯，增长45%，收入4170万美元，制造。

OptiMed Health Partners首席执行官将在PBM合同峰会上就行业合作和综合护理方法发表演讲。

PBM合同峰会分享了对影响PBM合同谈判的最新市场和法律复杂性的见解。

KALAMAZOO, Mich., August 11, 2017 (Newswire.com) - Andy Reeves, RPh, OptiMed Health Partners CEO, will be a keynote speaker at the 3rd annual PBM Contracting Summit to take place August 22-23, 2017, at the Warwick Allerton Hotel in Chicago. His topic of discussion will be Industry Collaboration and Integrated Care Approaches to Achieve Value.

“I’m honored to have been invited to speak at this great event,” said Reeves. “I’m looking forward to meeting new people and learning new perspectives on how to collaborate to increase value in the healthcare market.”

The PBM Contracting Summit, sponsored by CBI, shares insights into the latest market and legal complexities affecting PBM contract negotiations. Other topics of discussion will include, but not be limited to, the following:

• 通过深入了解 DIR 费用等问题，提高合同的财务价值。

• 定价透明

• 特种药品

• 隐私和数据考虑

• 价值型合同

Representatives from PBMs, health plans, retail pharmacies, and specialty pharmacies will be in attendance.

About OptiMed Health Partners: OptiMed Health Partners is an independently owned national healthcare organization headquartered in Kalamazoo, Mich., and is the parent company consisting of OptiMed Specialty Pharmacy and OptiMed Infusion Services. For more information about OptiMed, visit www.optimedhp.com or call 877-232-2857.

About CBI: CBI, a division of UBM Americas, is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies, and regulatory information through a dynamic conference platform that facilitates innovation, collaboration, and elevation across the pharmaceutical, biotechnology, medical device, and healthcare industries. For information about the PBM Contracting Summit, visit www.cbinet.com.

OptiMed Health公司合作销售ALS新药

Radicava是20多年来第一个获批的ALS治疗方案。

密歇根州卡拉马祖，2017年8月10日(新闻联播)-- OptiMed Health Partners将分销和管理新批准的Radicava(依达拉奉)，用于治疗肌萎缩侧索硬化症(ALS)患者，俗称卢伽雷氏病。由三菱田边制药美国公司生产的Radicava被FDA授予孤儿药称号，是20多年来首个获批的ALS治疗方案。

肌萎缩性脊髓侧索硬化症是一种罕见的渐进性疾病，会攻击和杀死控制自主肌肉的神经细胞。自愿性肌肉产生咀嚼、行走、呼吸和说话等动作。当神经细胞失去激活特定肌肉的能力时，肌肉就会变弱，从而导致瘫痪。据美国疾病控制和预防中心（CDC）估计，大约有12000到15000名美国人患有ALS。Radicava是一种静脉输液，将由OptiMed的输液专业人员进行。

"这是几十年来第一个治疗ALS的新药，我们对这种药物对这种衰弱性疾病患者的护理产生积极影响的潜力感到非常兴奋，"OptiMed Health Partners的首席执行官Andy Reeves博士说。"这种新的治疗方案与我们优化患者疗效和推进护理的承诺非常吻合。"

OptiMed Health Partners 是位于密歇根州卡拉马祖的 OptiMed Specialty Pharmacy 和 OptiMed Infusion Services 的母公司。OptiMed与患者和处方医生合作，为患者提供全面的护理方案，确保为每位患者安全、适当地使用Radicava等药物。我们为患者提供定制化教育、经济援助以及持续的监测和支持。

OptiMed拥有卫生保健认证委员会（ACHC）和URAC的双重专业药房认证，以及ACHC的流动输液中心和输液药房认证。

如需了解更多信息，请拨打877-232-2857联系OptiMed或访问www.optimedspecialtyrx.com。

OptiMed输液服务获得ACHC认证

该中心是密歇根州西南部第一个也是唯一一个独立的AIC，为患者、医疗服务提供者和支付方提供了一个安全、便捷、经济的门诊输液新选择。

密歇根州卡拉马祖，2017年7月5日（新闻联播）-- OptiMed Health Partners旗下的OptiMed输液服务最近获得了医疗保健认证委员会（ACHC）对其非住院输液中心（AIC）和家庭输液服务的认证。   

OptiMed的AIC是一个先进的设施，由一个在复杂静脉治疗方面经验丰富的多学科医疗团队指导。该中心是密歇根州西南部第一个也是唯一一个独立的AIC，为患者、医疗服务提供者和支付方提供了一个安全、便捷、经济的门诊输液新选择。

ACHC认证反映了一个医疗机构对达到行业标准的奉献和承诺，以促进更高水平的表现和病人护理。

"获得ACHC认证并不是必须的，但是，OptiMed这样做是为了证明我们对这些标准的承诺，以及我们在医疗保健领域提供卓越和优质服务的使命，"OptiMed Health Partners首席执行官Andy Reeves博士说。此外，OptiMed的专科药房业务还获得了ACHC和URAC的认证。

自1986年以来，ACHC已通过ISO 9001:2008认证，是一家非营利组织，是质量和卓越的象征。

OptiMed Health Partners 是由 OptiMed Specialty Pharmacy 和 OptiMed Infusion Services 组成的母公司。

如欲了解更多信息、介绍病人、预约输液或与您的健康计划签订合同，请拨打 OptiMed 输液服务电话 877-232-2857。

OptiMed Health Partners开设新的非住院输液中心

流动输液中心是密歇根州西南部第一个也是唯一一个独立的流动输液中心，可供接受门诊输液治疗的患者使用。

密歇根州卡拉马祖，2017年6月26日（新闻联播）-- OptiMed Specialty Pharmacy和OptiMed Infusion Services的所有者OptiMed Health Partners最近在其位于密歇根州卡拉马祖市科技大道6480号的专科药房总部内开设了一个新的非住院输液中心。该中心是密歇根州西南部第一个也是唯一一个独立的流动输液中心，可供接受门诊输液治疗的患者使用。

OptiMed的非住院输液中心是一个先进的设施，由一个在复杂的静脉治疗方面经验丰富的多学科医疗团队指导。该中心为患者、医疗服务提供者和支付方提供了一个安全、便捷和具有成本效益的门诊输液新选择。

"我们致力于在整个治疗过程中优化患者的治疗效果，"OptiMed Health Partners首席执行官Andy Reeves，RPh说。 "我们对新的输液中心感到非常兴奋，以及它如何增强我们的专科和家庭输液业务线，为以患者为中心的护理提供另一种具有成本效益的选择。"

输液中心提供各种设施，如补充Wi-Fi、个人流媒体设备、路边停车和灵活的排班，以增加患者的便利性和舒适性。 

该中心是OptiMed Health Partners推出的众多基于价值的举措之一。"我们的目标是通过适当的医疗场所管理，为患者提供最佳治疗，同时让他们尽可能地正常生活，从而实现医疗价值的最大化。"里夫斯说。

OptiMed在所有业务领域都采用"360度"的方法来护理病人。这种综合方法将病人视为一个"整体"，以制定全面的护理计划，同时考虑到影响病人健康的所有变量。欲了解更多信息，请致电 OptiMed 输液服务部，电话：877-232-2857。

OptiMed专科药房将分销新的类风湿关节炎药物。

OptiMed将配发新近获批的Kevzara（sarilumab），用于治疗成人中度至重度类风湿关节炎。

密歇根州卡拉马祖，2017年6月19日（新闻联播）--OptiMed专科药房将配发新近获批的Kevzara（sarilumab），用于治疗对其他修饰疾病的抗风湿药物反应不足的中度至重度类风湿关节炎成人。

类风湿关节炎(RA)是一种慢性炎症性自身免疫性疾病，免疫系统攻击关节组织，引起炎症、疼痛、关节损伤和残疾。凯夫扎拉是一种可注射的白细胞介素-6（IL-6）受体拮抗剂，可单独给药或与其他抗风湿药物联合使用。该药由赛诺菲和Regeneron共同销售。

"我们很高兴为患有这种经常使人衰弱的疾病的患者提供另一种治疗选择，"OptiMed首席执行官Andy Reeves，RPh说。"RA可能是一种难以治疗的疾病，拥有不同作用机制的较新疗法被证明对我们的患者有帮助。"

專科藥物（如 Kevzara）可能需要額外的監測，以保證安全性和有效性。OptiMed专科药房与患者和处方医生合作，为患者提供全面的护理方案，确保为每位患者安全、适当地使用药物。我们为患者提供个性化的教育、经济援助以及持续的监测和支持。OptiMed拥有卫生保健认证委员会（ACHC）和URAC的双重专科药房认证。

For more information, contact OptiMed at 877-232-2857 or visit www.optimedhp.com.

OptiMed Specialty Pharmacy被评为"西密歇根州最佳和最有前途的公司之一"

OptiMed因其卓越的人力资源实践、创新的解决方案和对员工的承诺而备受认可。

密歇根州卡拉马祖，2017年4月27日（新闻联播）-- OptiMed Specialty Pharmacy最近被评为"西密歇根州最佳与最有前途的公司®"之一。该奖项竞赛旨在表彰那些提供卓越的人力资源实践、创新的解决方案以及对员工做出令人印象深刻的承诺，创造更丰富的生活和建立更强大的工作场所的公司。

一家独立的研究公司根据几项标准对申请者进行评估，其中包括薪酬、福利和员工解决方案、员工充实、参与和保留、员工教育和发展、员工成就和认可、多样性和包容性、工作/生活平衡等。  

"OptiMed一直在努力改变员工的生活，提升他们的工作体验，"首席执行官Andy Reeves，RPh说。"凭借全公司的自豪感，对患者护理的承诺，以及解决被忽视的医疗挑战的诀窍，我们正在为我们的合作伙伴和我们所照顾的患者设立一个新的标准。"  

OptiMed Specialty Pharmacy将于5月3日（周三）在大急流城JW万豪酒店举行的颁奖典礼上受到表彰。

OptiMed专科药房首席执行官荣获卓越创新奖

颁奖典礼突出药学先驱们为行业重新注入活力，以满足未来患者的医疗保健需求。

密歇根州卡拉马祖，2017年4月25日（新闻联播）-- OptiMed Specialty Pharmacy自豪地宣布，其首席执行官Andy Reeves，RPh，最近获得了密歇根药剂师协会（MPA）颁发的卓越创新奖。  

要获得该奖项，药剂师必须展示出创新的药学实践计划，从而改善了患者的护理。该奖项强调了药学先驱们的工作和努力，他们为药学专业注入了新的活力，以满足未来患者的医疗保健需求。

Reeves的职业生涯中，通过确保药物治疗的依从性和加强疾病管理，有效地为患者服务。他一直在寻求扩大药剂师在医疗团队中的作用，并专注于以患者为中心的护理和降低医疗成本。他的工作推动了药学专业的发展，并展示了药师如何直接影响患者治疗的成功。最后，他在将药物基因检测带入门诊治疗方面发挥了重要作用，并创建了包括药剂师对实验室结果的解释以及更好地了解患者药物概况和潜在药物相互作用的模型。

Reeves曾在药房政治行动委员会董事会、MPA第三方委员会、药房代言人反应小组和密歇根西南药剂师协会任职。

OPTIMED SPECIALTY PHARMACY 总部位于密歇根州卡拉马祖市，是一家独立经营的全国性专科药房。凭借近25年的经验，OptiMed致力于为患者提供个性化的护理，并承诺优先考虑质量，最大限度地降低成本，并最大限度地提高患者的治疗效果。

密歇根州药剂师协会代表了密歇根州近9,000名药剂师和15,000名药剂师，努力为会员服务，提供支持、宣传和资源，最终改善患者护理、安全、健康和药学实践。